1,756 results match your criteria Giornale italiano di cardiologia 2006[Journal]


[Percutaneous left atrial appendage closure in a patient with atrial fibrillation and Rendu-Osler-Weber disease].

G Ital Cardiol (Rome) 2019 Apr;20(4):36-39

U.O. Cardiologia, Azienda Ospedaliera Universitaria di Parma.

Atrial fibrillation is the most common cardiac arrhythmia worldwide and represents a major risk factor for cerebral embolic stroke. The standard therapy in the prevention of stroke is oral anticoagulation therapy (OAT). However, a considerable number of patients are unable to tolerate chronic OAT. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1714/3146.31277DOI Listing

[Tricuspid regurgitation and indications for treatment].

G Ital Cardiol (Rome) 2019 Apr;20(4):27-35

Dipartimento Cardiovascolare, Azienda Sanitaria Universitaria Integrata di Trieste.

Tricuspid regurgitation is a frequent valvular heart disease, particularly in the elderly and in association with other left-sided heart diseases. It has an adverse prognostic impact, with progressively increasing mortality as the degree of regurgitation increases. Isolated or combined (with mitral and/or aortic) surgery remains the treatment of choice, provided operative risk is acceptable. Read More

View Article

Download full-text PDF

Source
http://www.giornaledicardiologia.it/articoli.php?archivio=ye
Publisher Site
http://dx.doi.org/10.1714/3146.31276DOI Listing
April 2019
1 Read

[What role for transcatheter mitral valve replacement?]

G Ital Cardiol (Rome) 2019 Apr;20(4):20-26

Cardiologia Clinica-UTIC ed Interventistica, IRCCS Policlinico San Donato, San Donato Milanese (MI).

Despite the safety and efficacy of transmitral valve repair techniques, transcatheter mitral valve replacement (TMVR) has emerged as a potential treatment option for patients with severe mitral regurgitation at high or prohibitive surgical risk. To date, over 250 high-risk patients with severe mitral regurgitation have been treated with 10 different TMVR devices, demonstrating the feasibility of this technique. Parallel to the potential advantages of this procedure (reproducible mitral regurgitation reduction, possibility of targeting all potential anatomic variations), many challenges has emerged during the design and implantation phases. Read More

View Article

Download full-text PDF

Source
http://www.giornaledicardiologia.it/articoli.php?archivio=ye
Publisher Site
http://dx.doi.org/10.1714/3146.31275DOI Listing
April 2019
1 Read

[A strategic roadmap of the Italian Society of Interventional Cardiology (SICI-GISE) to ensure patient's access to appropriate treatment].

G Ital Cardiol (Rome) 2019 Apr;20(4):4-19

A.O. Universitaria di Bologna, Policlinico S. Orsola-Malpighi, Bologna.

In comparison with the international scenario, in Italy the penetration of several important scientific and technological innovations in the field of cardiovascular intervention appears to be inadequate both in terms of number of patients treated with respect to the actual need, and inhomogeneity between the different geographical areas of the country. One of the main institutional objectives of the Italian Society of Interventional Cardiology (SICI-GISE) is to develop a roadmap to guarantee homogeneous access throughout the whole national territory to treatments that are recommended by the major international guidelines. The present document focuses on four main areas of cardiovascular intervention: (i) transcatheter treatment of aortic valve stenosis, (ii) percutaneous mitral valve repair, (iii) prevention of cardioembolic stroke through percutaneous left atrial appendage occlusion in patients with non-valvular atrial fibrillation, (iv) optimization of coronary revascularization with the aid of the functional study of coronary lesions. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1714/3146.31274DOI Listing
April 2019
1 Read

[Presentation].

G Ital Cardiol (Rome) 2019 Apr;20(4)

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1714/3146.31273DOI Listing

[Abnormal ECG findings in athletes].

Authors:
Pietro Delise

G Ital Cardiol (Rome) 2019 Apr;20(4):242-253

U.O. Cardiologia, Ospedale P. Pederzoli, Peschiera del Garda (VR).

Athlete's heart, as a consequence of exercise training, is characterized by hypervagotonia and enlargement of cardiac chambers. Such modifications influence the electrocardiogram. In fact, athletes frequently present with common cardiac alterations, including sinus bradycardia, first and second degree atrioventricular block, increased QRS voltage, and early repolarization. Read More

View Article

Download full-text PDF

Source
http://www.giornaledicardiologia.it/articoli.php?archivio=ye
Publisher Site
http://dx.doi.org/10.1714/3126.31077DOI Listing
April 2019
6 Reads

[Premature ventricular beats in young athletes: interpretation and diagnostic pathway].

G Ital Cardiol (Rome) 2019 Apr;20(4):229-241

Dipartimento di Scienze Cardiache, Toraciche, Vascolari e di Sanità Pubblica, Università degli Studi, Padova.

Adolescents and adults with cardiovascular disease who are engaged in sports activity have an increased risk of sudden cardiac death (SCD) related to the sports practice that acts as a trigger for life-threatening ventricular arrhythmias. Premature ventricular beats (PVBs) detected in athletes at the time of pre-participation screening may be a sign of heart disease at risk of SCD but are also found in athletes without cardiovascular abnormalities. Thus, the interpretation of PVBs could represent a clinical dilemma. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1714/3126.31076DOI Listing

[Premature ventricular beats: are they always benign? Diagnostic and therapeutic aspects].

G Ital Cardiol (Rome) 2019 Apr;20(4):223-228

U.O.S. Aritmologia, Cardiologia, Ospedale Maggiore, Bologna.

Premature ventricular complexes (PVCs) are usually benign, and commonly only severely symptomatic patients are treated. In the literature, frequent PVCs have been reported to cause ventricular dysfunction, which may improve after PVC treatment. PVCs can also worsen the prognosis in patients with structural heart disease. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1714/3126.31075DOI Listing
April 2019
1 Read

[How much frailty is important in cardiology?]

G Ital Cardiol (Rome) 2019 Apr;20(4):210-222

Dipartimento di Medicina Sperimentale e Clinica, Università degli Studi, Firenze, e S.O.D. Cardiologia Generale, Dipartimento Cardio-Toraco-Vascolare, Azienda Ospedaliero-Universitaria Careggi, Firenze.

Prevalence and incidence of cardiovascular diseases increase dramatically with advancing age, and older subjects account for the vast majority of patients seeking care either for acute and chronic cardiovascular disorders. In the same time, availability and improvements in drugs and devices, and innovative techniques in interventional cardiology and heart surgery procedures, increased as well, posing crucial challenges in clinical decision-making mainly in older people. Elderly subjects represent a very heterogeneous population and the interplay between underlying physiological change, chronic disease and multimorbidity can result in health states in older ages that are not fully captured by traditional disease classifications and that are often missing in disease-based assessments of health. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1714/3126.31074DOI Listing
April 2019
2 Reads

[The geriatric lexicon].

Authors:
Renzo Rozzini

G Ital Cardiol (Rome) 2019 Apr;20(4):204-209

Società Italiana di Cardiologia Geriatrica - Dipartimento di Geriatria, Fondazione Poliambulanza - Istituto Ospedaliero, Brescia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1714/3126.31073DOI Listing

[The challenges of cardiac surgery: innovation, critical mind and ethics].

G Ital Cardiol (Rome) 2019 Apr;20(4):198-203

U.O.C. Cardiochirurgia e Centro Trapianti di Cuore, Ospedale San Camillo-Forlanini, Roma.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1714/3126.31072DOI Listing
April 2019
2 Reads

[The MITRA-FR and COAPT trials: the interventional cardiologist's point of view].

G Ital Cardiol (Rome) 2019 Apr;20(4):194-197

U.S.C. Cardiologia, Ospedale Santa Croce e Carle, Cuneo.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1714/3126.31071DOI Listing

[The MITRA-FR and COAPT trials: the clinical cardiologist's point of view].

G Ital Cardiol (Rome) 2019 Apr;20(4):190-193

U.O.C. Cardiologia, Dipartimento Cardiovascolare, ASST Papa Giovanni XXIII, Bergamo.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1714/3126.31070DOI Listing

[The ODYSSEY OUTCOMES trial].

G Ital Cardiol (Rome) 2019 Apr;20(4):187-189

U.S.C. Cardiologia, Ospedale Santa Croce e Carle, Cuneo.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1714/3126.31069DOI Listing

In questo numero.

Authors:

G Ital Cardiol (Rome) 2019 Apr;20(4)

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1714/3126.31068DOI Listing

[Combined percutaneous procedure of mitral valve repair with the edge-to-edge technique and left atrial appendage occlusion].

G Ital Cardiol (Rome) 2019 Mar;20(3):35-39

Dipartimento di Scienze Cardiache, Toraciche e Vascolari, Policlinico Universitario di Padova.

Percutaneous mitral valve repair (MVR) using MitraClip system has been shown to be effective in patients with severe symptomatic mitral regurgitation deemed at high surgical risk. Atrial fibrillation is frequently observed in this setting, and the presence of a contraindication to oral anticoagulation is also very common in these patients. In this context, percutaneous left atrial appendage occlusion (LAAO) may be a valid alternative in reducing the thromboembolic risk. Read More

View Article

Download full-text PDF

Source
http://www.giornaledicardiologia.it/articoli.php?archivio=ye
Publisher Site
http://dx.doi.org/10.1714/3121.31040DOI Listing
March 2019
5 Reads

[Role of carotid artery stenting in stroke prevention].

G Ital Cardiol (Rome) 2019 Mar;20(3):28-34

Cattedra di Malattie dell'Apparato Cardiovascolare, Dipartimento di Scienze Biomediche Avanzate, Università degli Studi "Federico II", Napoli.

Carotid revascularization is an effective method of primary and secondary prevention of ischemic cerebral stroke in patients presenting with extracranial carotid atherosclerosis leading to significant stenosis of the internal carotid artery. Currently, the European guidelines recommend surgical revascularization in all symptomatic patients with >50% stenosis with a documented periprocedural death/stroke risk of <6%. Endovascular revascularization should be considered in symptomatic patients with anatomical and clinical features that contribute to making such patients at high surgical risk. Read More

View Article

Download full-text PDF

Source
http://www.giornaledicardiologia.it/articoli.php?archivio=ye
Publisher Site
http://dx.doi.org/10.1714/3121.31039DOI Listing
March 2019
6 Reads

[Antithrombotic approaches in patients undergoing left atrial appendage occlusion: current evidence and future perspectives].

G Ital Cardiol (Rome) 2019 Mar;20(3):23-27

Dipartimento di Malattie dell'Apparato Cardiovascolare, Policlinico Campus Bio-Medico, Roma.

Percutaneous left atrial appendage occlusion is a novel therapeutic option for stroke prevention in patients with atrial fibrillation and contraindication to oral anticoagulant therapy. However, after left atrial appendage occlusion with the most commonly used devices, a short period of antithrombotic therapy is indicated to allow complete endothelialization of the device and to prevent device thrombosis. Post-procedure antithrombotic strategies are often performed empirically, because of the lack of clear evidence. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1714/3121.31038DOI Listing

[Epidemiology of stroke and cerebral protection in patients undergoing transcatheter aortic valve replacement].

G Ital Cardiol (Rome) 2019 Mar;20(3):17-22

Dipartimento di Cardiologia, IRCCS Policlinico S. Donato, San Donato Milanese (MI).

The introduction into clinical practice of transcatheter aortic valve implantation (TAVI) has led to a significant change in the therapeutic paradigm for patients with valvular aortic stenosis. However, in parallel with the benefits obtained in prognosis and quality of life, an inherent risk of major cerebral thromboembolic events has been observed. In different studies this risk has been estimated between 2% and 6%. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1714/3121.31037DOI Listing

[Patent foramen ovale closure: how to choose the right device for the right patient].

G Ital Cardiol (Rome) 2019 Mar;20(3):9-16

Interventistica Cardiologica Strutturale, Dipartimento Cardio-Toraco-Vascolare, AOU Careggi, Firenze.

Percutaneous patent foramen ovale (PFO) closure is an intervention aimed to prevent cardioembolic stroke. It recently proved to be superior to antiplatelet therapy in preventing recurrent strokes in a well-selected population of patients with a previous cryptogenic cerebral ischemic event. A large part of the clinical advantage of PFO transcatheter therapy derives from the very high efficacy and safety of the maneuver. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1714/3121.31036DOI Listing
March 2019
1 Read

[What's new in the management of patients with patent foramen ovale?]

G Ital Cardiol (Rome) 2019 Mar;20(3):4-8

U.O.C. Emodinamica, P.O. San Filippo Neri, ASL Roma 1, Roma.

Patent foramen ovale (PFO) is associated with a number of clinical syndromes in which it plays variable roles that, often, cannot be accurately determined. This situation creates conflicting data and controversial studies. However, in 2017 and 2018, four randomized clinical trials have been published, allowing for the clarification of certain issues pertaining to cryptogenic stroke. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1714/3121.31035DOI Listing
March 2019
1 Read

[Presentation].

Authors:
Francesco Saia

G Ital Cardiol (Rome) 2019 Mar;20(3)

Guest Editor.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1714/3121.31034DOI Listing

[ANMCO/GISE/SICCH Inter-Society Consensus Document: Antithrombotic therapy after surgery or structural interventional procedures for valvular heart diseases: how to treat postoperative complications].

G Ital Cardiol (Rome) 2019 Mar;20(3):149-186

U.O.C. Cardiologia, Ospedale Garibaldi-Nesima, Azienda di Rilievo Nazionale e Alta Specializzazione "Garibaldi", Catania - Fondazione per il Tuo cuore - Heart Care Foundation Onlus, Firenze.

Continuous improvement of technologies, devices and drugs needs a renewal and update of current recommendations and guidelines on antithrombotic strategies, especially in those fields where literature lacks of established scientific evidences. Accordingly, the aim of this consensus statement is to provide support for antithrombotic therapy based on current guidelines and the most recent scientific evidences.After an overview on the currently available devices, the appropriate therapy according to type of procedure and implanted device is discussed. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1714/3108.30964DOI Listing
March 2019
5 Reads

[The Pacemaker and Implantable Cardioverter-Defibrillator Registry of the Italian Association of Arrhythmology and Cardiac Pacing - Annual report 2017].

G Ital Cardiol (Rome) 2019 Mar;20(3):136-148

Dipartimento di Medicina Ambientale e Salute Pubblica, Università degli Studi, Padova.

Background: The pacemaker (PM) and implantable cardioverter-defibrillator (ICD) Registry of the Italian Association of Arrhythmology and Cardiac Pacing (AIAC) monitors the main epidemiological data in real-world practice. The survey for the 2017 activity collects information about demographics, clinical characteristics, main indications for PM/ICD therapy and device types from the Italian collaborating centers.

Methods: The Registry collects prospectively national PM and ICD implantation activity on the basis of European cards. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1714/3108.30963DOI Listing
March 2019
6 Reads

[Heart failure and iron deficiency].

G Ital Cardiol (Rome) 2019 Mar;20(3):126-135

U.O. Scompenso e Cardiomiopatie, U.O.C. Cardiologia, Ospedale G. da Saliceto, AUSL Piacenza.

Heart failure with reduced ejection fraction (HFrEF) is a clinical reality with an incidence of >10% in the population over 65 years of age, expected to increase in the coming years. Alongside the well-known pharmacological options (e.g. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1714/3108.30962DOI Listing
March 2019
2 Reads

[The COMMANDER-HF trial].

G Ital Cardiol (Rome) 2019 Mar;20(3):123-125

Cattedra e Divisione di Cardiologia, Università degli Studi e Spedali Civili, Brescia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1714/3108.30961DOI Listing

In questo numero.

Authors:

G Ital Cardiol (Rome) 2019 Mar;20(3)

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1714/3108.30960DOI Listing

[Giant negative T waves on the electrocardiogram: what is underneath?]

G Ital Cardiol (Rome) 2019 Feb;20(2):120-121

Unità di Cardiologia, Ospedale "Madonna delle Grazie", Matera.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1714/3093.30860DOI Listing
February 2019

[Infero-postero-lateral acute myocardial infarction caused by left ventricular myxoma embolism].

G Ital Cardiol (Rome) 2019 Feb;20(2):117-119

Divisione di Cardiologia, Dipartimento di Medicina Interna, Ospedale Maria Vittoria, Torino.

The majority of myxomas are located in the left atrium (75%) followed by the right atrium (20%). In rare cases, myxomas can be found in the ventricles, with 2.5% reported for myxomas in the left ventricle. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1714/3093.30859DOI Listing
February 2019
1 Read

[Surgical management of hypertrophic obstructive cardiomyopathy: the role of mitral valve].

G Ital Cardiol (Rome) 2019 Feb;20(2):109-116

Unità di Cardiochirurgia, Dipartimento per la Cura e lo Studio delle Patologie Cardiotoraciche e dei Trapianti Cardiotoracici, IRCCS-ISMETT (Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione), Palermo.

Hypertrophic obstructive cardiomyopathy (HOCM) is the most frequently inherited cardiovascular disease (prevalence in the general population of 1/500) and is characterized by significant left ventricular hypertrophy, especially in the interventricular septum, combined with small-volume cardiac cavities. Transaortic surgical septal myectomy is the most commonly used technique to treat HOCM, and is associated with low operative morbidity and mortality and a reduction of the outflow gradients. The composite operative mortality of only 0. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1714/3093.30858DOI Listing
February 2019
1 Read

[Treatment of secondary ischemic mitral regurgitation: controversial issues].

G Ital Cardiol (Rome) 2019 Feb;20(2):97-108

Centro Cardiologico Universitario e LTTA Centre, Università degli Studi, Ferrara - Maria Cecilia Hospital, GVM Care & Research, E.S. Health Science Foundation, Cotignola (RA).

The presence of secondary mitral regurgitation is an unfavorable prognostic factor in patients with chronic ischemic heart disease. This type of regurgitation can be treated with medical therapy, cardiac resynchronization therapy, surgically or percutaneously but each strategy has controversial aspects. The purpose of this review is to discuss the most debated issues relative to the various modalities available to treat ischemic secondary mitral regurgitation, highlighting also future perspectives. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1714/3093.30857DOI Listing
February 2019
1 Read

[New therapeutic options for the treatment of tricuspid regurgitation].

G Ital Cardiol (Rome) 2019 Feb;20(2):85-96

Unità di Cardiologia Interventistica, IRCCS Ospedale San Raffaele, Milano.

Tricuspid regurgitation is a common finding in patients with left-sided heart disease with prognostic implications. In addition, isolated tricuspid valve surgery is associated with high mortality and is infrequently performed. Hence, a largely unmet clinical need exists and less invasive therapeutic options are emerging: multiple percutaneous therapies have been developed, including tricuspid valve repair or replacement. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1714/3093.30856DOI Listing
February 2019

[Transcatheter closure of patent foramen ovale in patients with cryptogenic stroke].

G Ital Cardiol (Rome) 2019 02;20(2):73-84

Cardiologia Pediatrica e dell'Età Evolutiva, Centro per il Trattamento del Cardiopatico Congenito Adulto, Policlinico S. Orsola-Malpighi, Università degli Studi, Bologna.

Treatment of patients with cryptogenic stroke and a patent foramen ovale (PFO) has always been a matter of discussion. A clear pathogenic relationship is difficult to demonstrate in most cases, also because of the high prevalence of a PFO in the general population (25-30%). Early randomized trials failed to demonstrate a superiority of PFO transcatheter closure with respect to medical therapy alone but more recent data, coming from new randomized trials, strongly suggest that PFO closure associated with antiplatelet therapy is more effective than antiplatelet therapy alone in preventing recurrent stroke, with no increased risk of major adverse cardiovascular events in the follow-up; only a higher incidence of atrial fibrillation has been reported after PFO closure. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1714/3093.30855DOI Listing
February 2019
1 Read

[Generic medicinal products: if you know them, you do not avoid them].

G Ital Cardiol (Rome) 2019 Feb;20(2):66-72

U.O.C. Cardiologia, Ospedali dell'Ovest Vicentino, Azienda ULSS 8 Berica, Arzignano (VI).

Although equivalent (generic) medicinal products have been introduced in the Italian market since decades, Italy is still among the latest for prescription of equivalent medicinal products. Several reasons may explain this behavior such as a scant familiarity with equivalent medicinal products, a general skepticism toward "not branded-named" medications and an "indolent laziness" both by specialists and general practitioners. Yet, the wider use of the generic drug could: (i) save economical resources for the National and Regional Health Services and allow to allocate them in clinical research and development of new therapies; (ii) reduce the economic burden for the patients by saving the brand drug-related co-payments, especially if they are on polytherapy. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1714/3093.30854DOI Listing
February 2019

[Aspirin in primary prevention: the ARRIVE, ASCEND and ASPREE aftermath].

Authors:
Stefano Urbinati

G Ital Cardiol (Rome) 2019 Feb;20(2):63-65

U.O.C. Cardiologia, Ospedale Bellaria, Bologna.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1714/3093.30853DOI Listing
February 2019

In questo numero.

Authors:

G Ital Cardiol (Rome) 2019 Feb;20(2)

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1714/3093.30852DOI Listing
February 2019

[Palliative care in the cardiac setting: a consensus document of the Italian Society of Cardiology/Italian Society of Palliative Care (SIC/SICP)].

G Ital Cardiol (Rome) 2019 Jan;20(1):46-61

Presidente SIC, Struttura Cardiologica, Policlinico Universitario, Cagliari.

Palliative care is recognized as an approach that improves quality of life of patients and families facing life-threatening illnesses. This is achieved through prevention, early identification, assessment and treatment of symptoms and other psycho-social, spiritual and economic issues. Palliative care is not dependent on prognosis and can be delivered as "simultaneous care", together with disease-modifying treatments and adequate symptom relief. Read More

View Article

Download full-text PDF

Source
http://www.giornaledicardiologia.it/articoli.php?archivio=ye
Publisher Site
http://dx.doi.org/10.1714/3079.30720DOI Listing
January 2019
24 Reads

[Subcutaneous defibrillator implantation with ultrasound-guided serratus block using the two-incision technique: our experience].

G Ital Cardiol (Rome) 2019 Jan;20(1):41-45

U.O.C. Cardiologia-UTIC.

Background: The aim of this study was to report our experience with subcutaneous defibrillator (S-ICD) implantation.

Methods: At our hospital, 7 procedures of S-ICD implantation were performed; 4 of these with ultrasound-guided serratus anterior plane block (SAPB) and 3 with usual local anesthesia followed by sedation.

Results: Surgical operations were not burdened with peri- and postprocedural complications, with only one event of limited hematoma of the thoracic wall. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1714/3079.30719DOI Listing
January 2019
1 Read

[Leadless pacing: present and future of cardiac stimulation].

G Ital Cardiol (Rome) 2019 Jan;20(1):32-40

Dipartimento di Scienze Cardiovascolari, Respiratorie, Nefrologiche, Anestesiologiche e Geriatriche, Sapienza Università di Roma, Roma.

Leadless pacemaker therapy now represents a reality in the field of cardiac pacing. It was developed with the aim of reducing post-procedural complications due to endocavitary leads and with the intention to propose itself as a valid alternative in patients who have contraindications to conventional pacing. Leadless pacemakers to date allow right ventricular stimulation and are implanted through a percutaneous venous femoral access. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1714/3079.30718DOI Listing
January 2019
2 Reads

[Lifestyle, risk factors and prevention of cancer: role of the cardiologist].

G Ital Cardiol (Rome) 2019 Jan;20(1):20-31

U.O. Riabilitazione, Humanitas Gavazzeni, Bergamo.

Although commonly thought of as two separate disease entities, cardiovascular diseases and cancer, the leading causes of death, possess various possible interactions, including a number of similar risk factors (e.g. obesity, diabetes, chronic inflammation). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1714/3079.30717DOI Listing
January 2019
2 Reads

[Clinical applications of cardiac magnetic resonance imaging: coronary heart disease, myocarditis, pericardial diseases, arrhythmias, valvular heart disease, congenital heart disease and cardiac masses].

G Ital Cardiol (Rome) 2019 Jan;20(1):8-19

Dipartimento Cardiovascolare, ASST Papa Giovanni XXIII, Bergamo.

Cardiac magnetic resonance is an accurate and versatile tool for multiparametric morphologic and functional evaluation of the heart and great vessels, with a wide range of clinical applications: from acute and chronic ischemic heart disease to the assessment of the substrate of complex ventricular arrhythmias and the follow-up of patients with valvular and congenital heart disease. The accuracy in cardiac volume and ejection fraction quantification, tissue characterization, valvular regurgitant fraction and cardiac shunt assessment, pharmachologic stress myocardial perfusion and three-dimensional reconstruction of great vessels are the points of strength that have made Cardiac magnetic resonance an invaluable tool for diagnostic, classification and follow-up of patients with various cardiac diseases. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1714/3079.30716DOI Listing
January 2019
2 Reads

[Five questions for the clinician after the publication of the COMPASS trial].

Authors:
Leonardo De Luca

G Ital Cardiol (Rome) 2019 Jan;20(1):1-7

U.O.C. Cardiologia, Ospedale San Giovanni Evangelista, Tivoli (RM).

View Article

Download full-text PDF

Source
http://www.giornaledicardiologia.it/articoli.php?archivio=ye
Publisher Site
http://dx.doi.org/10.1714/3079.30715DOI Listing
January 2019
12 Reads

In questo numero.

Authors:

G Ital Cardiol (Rome) 2019 Jan;20(1)

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1714/3079.30714DOI Listing
January 2019
1 Read

[When a purely observational approach does not provide reliable evidence].

G Ital Cardiol (Rome) 2018 Dec;19(12):727-728

Centro Studi ANMCO, Fondazione per il Tuo cuore - HCF onlus, Firenze.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1714/3027.30258DOI Listing
December 2018
1 Read

[Intravascular ultrasound-guided antegrade recanalization of a complex chronic total occlusion of the left anterior descending coronary artery: a case report].

G Ital Cardiol (Rome) 2018 Dec;19(12):724-726

U.O.C. Cardiologia Interventistica-UTIC, Ospedale Santo Spirito, Pescara.

Patients with coronary chronic total occlusion (CTO) if symptomatic for angina or with extensive inducible ischemia at provocative tests may be revascularized percutaneously or surgically. Percutaneous revascularization can be performed by antegrade or retrograde approach. In our case, in the presence of a long CTO of the left anterior descending coronary artery, the antegrade approach was chosen using an intravascular ultrasound (IVUS) catheter positioned in a secondary branch, to accurately identify the proximal lesion cap. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1714/3027.30257DOI Listing
December 2018
7 Reads

[Regional network for ST-elevation myocardial infarction in Italy: from development to management].

G Ital Cardiol (Rome) 2018 Dec;19(12):721-723

U.O.C. Cardiologia, Ospedale Maggiore, Bologna.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1714/3027.30256DOI Listing
December 2018
2 Reads

[The second multicenter observational registry on the management of acute ST-elevation myocardial infarction in the Veneto Region (VENERE 2)].

Authors:

G Ital Cardiol (Rome) 2018 Dec;19(12):714-720

Background: We sought to evaluate the epidemiology and the management of ST-elevation acute myocardial infarction (STEMI) in the Veneto Region (VENERE 2) in 2014, 10 years after a similar survey conducted in the early 2000s.

Methods: Between October 2014 and March 2015, all consecutive patients admitted to the Cardiology Divisions of the Veneto Region with STEMI were enrolled in an observational, prospective, multicenter register, called VENERE 2. The main diagnostic and therapeutic efficiency indicators were analyzed and compared with data from the previous VENERE study performed 10 years earlier. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1714/3027.30255DOI Listing
December 2018
4 Reads

[The coronary sinus Reducer: a new opportunity for refractory angina. Comparison between Italian experiences].

G Ital Cardiol (Rome) 2018 Dec;19(12):705-713

Divisione di Cardiologia Interventistica, Dipartimento Cardio-Toraco-Vascolare, Istituto Scientifico San Raffaele, Milano.

Refractory angina is a disabling condition that afflicts patients in whom we have no more strategy to improve their quality of life. This phenomenon has been increasing over the last years due to longer life expectancy, also resulting in a significant impact upon healthcare resources. The coronary sinus Reducer is a novel technology designed to improve the quality of life of these patients. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1714/3027.30254DOI Listing
December 2018
3 Reads